Weight-loss Drug Response Varies, But Why?

• May 5, 2026

This Week’s CGT News: CRISPR Hits Phase 3 Milestone

Intellia’s one-time HAE therapy delivers strong results as Cabaletta strikes CAR-T manufacturing deal

• May 4, 2026

• 7 min

Bridging the Diabetic Eye Care Divide

Study evaluates eye care utilization of diabetic patients in Northern Uganda, spotlighting limited health literacy and awareness as determining factors in care

• May 1, 2026

• 3 min

This Week’s Biopharma News: Wave of Antibody Approvals

FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars

• April 28, 2026

• 5 min